Recent Phase I vaccine trials

Below is a list of phase I trials performed since 2011, for trials conducted before, contact: cev@uantwerpen.be

Proof Of Concept Study: Immunogenicity and Safety of Hepatitis B Injection in the Dermis in Healthy Volunteers Using an Intradermal Injection Device (VAX-ID)

  • ClinicalTrials.gov Identifier: NCT02186977
  • Phase: I
  • Population age: adults (18 to 35y)
  • Gender: male,female
  • Starting year @CEV: 2016

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the Investigational GSK Biologicals' GSK3277511A Vaccine in Adults.

  • EudraCT number: 2015-000378-36
  • ClinicalTrials.gov Identifier: NCT02547974
  • Sponsor protocol number: 201281
  • Centre code: NTHI MCAT-001
  • Phase: I
  • Population age: adults (18 to 40y &  50-70y with smoking history)
  • Gender: male,female
  • Starting year @CEV: 2015

Safety, Tolerability, and Immunogenicity Study of a Cell-based Virosomal Influenza Vaccine in Healthy Adults

  • EudraCT number:2014-000573-39
  • ClinicalTrials.gov Identifier: NCT02148328
  • Sponsor protocol number: Flucell
  • Centre code:
  • Phase: I
  • Population age: adults (18 to 49y)
  • Gender: male,female
  • Starting year @CEV: 2014

Clinical Study for Safety and Immunogenicity Study of Influenza Vaccine

  • EudraCT number: 2012-001693-28
  • ClinicalTrials.gov Identifier: NCT01617239
  • Sponsor protocol number: INF-V-A017
  • Centre code:
  • Phase: I
  • Population age: adults (18 to 50y)
  • Gender: male,female
  • Starting year @CEV: 2012

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Non-typeable Haemophilus Influenzae (NTHi) Investigational Vaccine (GSK2838497A) in Current and Former Smokers

  • EudraCT number: 2012-001238-32
  • ClinicalTrials.gov Identifier: NCT01678677
  • Sponsor protocol number: NTHI-003
  • Centre code:
  • Phase: I
  • Population age: adults (50 to 70y, smokers)
  • Gender: male,female
  • Starting year @CEV: 2012